Sharman, Jeffrey P.
Mayo Clinic
Willamette Valley Cancer Institute and Research Center
Citations 3
99 | FIXED DURATION SUBCUTANEOUS MOSUNETUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH‐TUMOR BURDEN FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM THE PHASE II MORNINGSUN STUDY
Burke, John M. , Sharman, Jeffrey P., Anz, Bertrand, Zuniga, R., Jani, Piyush, Biondo, Juliana M.L., Mun, Yong, Chopra, Vishal , Farighi, Rona, Lin, Tao , Budde, Lihua E. , Tun, Aung M. , Jani, P., Wu, Ming‐Shiou , Chopra, V. S., Lin, T., Villasboas, José C. , Flinn, Ian W.
Hematological Oncology | June 17, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS
Andorsky, David , Coleman, Morton , Yacoub, Abdulraheem , Melear, Jason M., Fanning, Suzanne, Kolibaba, K. S., Reynolds, C. , Nowakowski, Grzegorz S. , Gharibo, Mecide, Ahn, J. R., Rummel, Mathias , Sharman, Jeffrey P., Lansigan, Frederick , Reynolds, C., Li, J.
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1043-1044
INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
Sharman, Jeffrey P., Melear, Jason M., Yacoub, Abdulraheem , Fanning, Suzanne, Andorsky, David , Nowakowski, Grzegorz S. , Rummel, Mathias , Lansigan, Frederick , Ahn, J. R., Gharibo, Mecide, Coleman, Morton , Lansigan, Frederick , Li, J.
Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available